Antibody Production Market, By Type (Polyclonal Antibody and Monoclonal Antibody), By Process (Upstream Processing [Bioreactors and Consumables], Downstream Processing [Chromatography Systems and Chromatography Resins], Filtration [Filtration Systems and Filtration Consumables and Accessories]), By End-Use (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Research Institutes), and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The global antibody production market was valued at USD 10.27 billion by 2019, growing with 15.1% CAGR during the forecast period, 2021-2027.
The National Human Genome Research Institutes (NHGRI) defined antibody as a protein component of the immune system, whose function comprises of blood circulation, recognition of the foreign substance like bacteria and virus in the blood, and neutralize them. After the exposure of foreign substances, so-called antigens, antibodies get activated, continue their circulation in bodies, and protect the host from future antigens.
Antibodies play an essential role in treating several health conditions, including rheumatoid arthritis, cancers, psoriasis, multiple sclerosis, etc. Antibody production refers to the creation of a specific antibody, involving numerous steps, like immunogen preparation, immunization, hybridoma creation, collection, screening, isotyping, purification, and labeling. The production of antibodies can be done in the host animal and through additional procedures in the laboratories.
Market Dynamics
Antibody production is widely adopted in the medical industry for research and development purposes. Thus, the growing demand for therapeutic antibodies, the adoption of targeted therapy, and the U.S. FDA clearance of therapeutic mAbs are the key determiners responsible for the global antibody production market growth. The demand for the production of antibodies is also influenced by the increasing prevalence of chronic diseases such as cancer, rheumatic heart disease, and arthritis; as these conditions can be treated with antibodies. As per the data revealed by the American Cancer Society (ACS), in 2019, in the US only, the estimated number of newly diagnosed cancer cases reached 1,762,450, whereas the death count was 606,880.
Furthermore, the rising risk of infectious disease, like COVID-19, and the escalating demand for protein therapeutics are responsible for elevating the market potential. As per the data updated by the World Health Organization (WHO), the count of coronavirus infected patient’s cases was 12,964,809; whereas the number of deaths was recorded more than 570,000, as of mid-July 2020. On the contrary, the key global antibody production market restraints account for the high cost of the primary antibodies, which will hamper the demand during the forecast period.
Type Takeaway
The type segment is bifurcated into polyclonal and monoclonal antibody. The monoclonal antibody segment is further divided into Murine, Chimeric, and Humanized. This segment is estimated to have the maximum market share during the upcoming decade, accounting for the increasing investment by key players for the development of such antibodies along with the high product demand for the treatment of chronic diseases.
Flip-side, the polyclonal antibody segment witnesses a fast growth rate in the near future. The demand for the polyclonal antibody is predominately influenced by the growing demand for therapeutic antibodies, and the intensifying R&D investments. For instance, in July 2020, Massachusetts based biotechnology company, Revitope Oncology Inc. Oncology Inc. collaborated with Shanghai Junshi Biosciences Co. Ltd. to develop antibody-based immune therapies for cancer. As per the collaboration, both the companies will explore next-generation immunotherapies with precision-targeted T-cell engaging antibodies.
Process Takeaway
Based on the process, the industry is fragmented into upstream processing, downstream processing, and filtration process. The upstream processing is further divided into consumables and bioreactors. The bioreactors sub-segment includes large-scale bioreactors and single-use bioreactors; whereas the consumables sub-segment comprises of media & buffers and reagents. Switching back to the downstream processing segment, this process is broadly categorized into chromatography and chromatography resins. Lastly, the filtration segment includes filtration systems and filtration accessories and consumables.
The downstream processing segment dominates the market and is likely to grow at the same pace in the study period, followed by upstream processing. Factors impacting the demand include the commercial success of biopharmaceuticals products that further aids in boosting the demand for innovation in bioprocessing along with the application of accurate and efficient products including chromatography instruments and resins. Besides, the increasing investment in production infrastructure by manufacturers is responsible for propelling the growth of the upstream process. Nevertheless, the usage of advanced bioreactors and filters is likely to influence the filtration process segment in the future.
End-Use Takeaway
Depending upon end-users, the industry is categorized into pharmaceutical & biotechnology companies, research institutes, and diagnostic laboratories. The pharmaceutical and biotechnology segment is taking deep dive into the biotechnology industry, which is anticipated to offer potential growth and development in the global market. Increasing research and development spending by key vendors along with the expanding count of strategic collaborations among companies support the segment growth.
For instance, in June 2020, GlaxoSmithKline collaborated with U.S. based biotech firm, Vir Biotechnology. As a part of the partnership, GSK is likely to invest US$250 million for R&D activities that are designed to advance COVID-19 candidates into Phase II clinical trials.
Regional Takeaway
Regionally, the overall market is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. In 2019, North America has registered the majority of share followed by Europe and the Asia Pacific. Increasing government expenditure for new product development, presence of key players, and the rising cases of cancer are the key determiners supporting the growth of North America’s antibody production market potential. Strong growth industry players such as GE Healthcare, Thermo Fisher Scientific, Inc., Pall Corporation, and FiberCell Systems Inc. are supporting these reginal growths. Contrary, the Asia Pacific is anticipated to be the fastest-growing region throughout the forecast owing to the untapped opportunities available in this region coupled with the developing healthcare infrastructure.
COVID-19 Impact
The sudden outbreak of the coronavirus, as an infectious disease, has positively influenced the growth of the antibody production market. The demand for a cure, capable of treating COVID, is increasing exponentially concerning the growing confirmed cases per day. The demand for antibodies is predominately influenced by rising investments by many companies in the search for the cure via the production of antibodies. For instance, in April 2020, Astra Zeneca collaborated with the government and academia for the discovery of novel coronavirus-neutralizing antibodies.
Key Vendor Takeaway
The leading players of the global antibody production market include Eppendorf AG, Cellab GmbH, FiberCell Systems Inc., GE Healthcare, Merck KGaA, INTEGRA Biosciences, Sartorius AG, Thermo Fisher Scientific, and Pall Corporation.
Key players are continuously making efforts to enhance their business portfolio via new product developments, research collaborations, investments in the development of vaccines, etc. Such developments may account for the Thermo Fisher Scientific Inc. collaboration with WuXi Diagnostics and Mayo Clinic in May 2020. According to the collaboration, Thermo Fisher expanded its product portfolio with the development of a total antibodies test to combat COVID-19. The test is designed to run on an open instrument platform, and the determination of antibody status will aid in the diagnosis of the disease during the acute and recovery stages of infection.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2021 to 2027
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBODY PRODUCTION MARKET KEY PLAYERS
- Cellab GmbH
- Eppendorf AG
- FiberCell Systems Inc.
- GE Healthcare
- INTEGRA Biosciences AG
- Merck KGaA
- Pall Corp.
- Sartorius AG
- Thermo Fisher Scientific, Inc.
GLOBAL ANTIBODY PRODUCTION MARKET, BY PRODUCTION
- Monoclonal antibody
- Chimeric
- Murine
- Humanized
- Polyclonal antibody
GLOBAL ANTIBODY PRODUCTION MARKET, BY PROCESS
- Upstream Processing
- Consumables
- Media
- Buffers And Reagents
- Bioreactors
- Large-Scale Bioreactors
- Single-Use Bioreactors
- Downstream Processing
- Chromatography Resins
- Chromatography Systems
- Filtration
- Filtration Systems
- Filtration Consumables and Accessories
- Consumables
GLOBAL ANTIBODY PRODUCTION MARKET, BY END-USE
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Diagnostic Laboratories
- Others
GLOBAL ANTIBODY PRODUCTION MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. ANTIBODY PRODUCTION MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Production
2.1.2. Market Snippet by Process
2.1.3. Market Snippet by End-Use
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. ANTIBODY PRODUCTION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. ANTIBODY PRODUCTION INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. ANTIBODY PRODUCTION MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. ANTIBODY PRODUCTION MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. ANTIBODY PRODUCTION MARKET – BY PRODUCTION
7.1. Overview
7.1.1. Segment Share Analysis, By Production, 2020 & 2027 (%)
7.2. Polyclonal antibody
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
7.3. Monoclonal antibody
7.3.1. Murine
7.3.1.1. Overview
7.3.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
7.3.2. Chimeric
7.3.2.1. Overview
7.3.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
7.3.3. Humanized
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8. ANTIBODY PRODUCTION MARKET – BY PROCESS
8.1. Overview
8.1.1. Segment Share Analysis, By Process, 2020 & 2027 (%)
8.2. Upstream processing
8.2.1. Bioreactors
8.2.1.1. Large-scale bioreactors
8.2.1.1.1. Overview
8.2.1.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.2.1.2. Single-use bioreactors
8.2.1.2.1. Overview
8.2.1.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.2.2. Consumables
8.2.2.1. Media
8.2.2.1.1. Overview
8.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.2.2.2. Buffers and Reagents
8.2.2.2.1. Overview
8.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.3. Filtration
8.3.1. Filtration Systems
8.3.1.1. Overview
8.3.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.3.2. Filtration Consumables and Accessories
8.3.2.1. Overview
8.3.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.4. Downstream processing
8.4.1. Chromatography Systems
8.4.1.1. Overview
8.4.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
8.4.2. Chromatography Resins
8.4.2.1. Overview
8.4.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
9. ANTIBODY PRODUCTION MARKET – BY END-USE
9.1. Overview
9.1.1. Segment Share Analysis, By End-Use, 2020 & 2027 (%)
9.2. Pharmaceutical and Biotechnology Companies
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
9.3. Research Institutes
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
9.4. Diagnostic Laboratories
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10. ANTIBODY PRODUCTION MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
10.2.4. North America Market Size and Forecast, By Production, 2016 – 2027 (US$ Million)
10.2.5. North America Market Size and Forecast, By Process, 2016 – 2027 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-Use, 2016 – 2027 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Production, 2016 – 2027 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Process, 2016 – 2027 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-Use, 2016 – 2027 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.3.11. Rest of Europe
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in the Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Production, 2016 – 2027 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Process, 2016 – 2027 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2016 – 2027 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.4.11. Rest of APAC
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Production, 2016 – 2027 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Process, 2016 – 2027 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-Use, 2016 – 2027 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.5.10. Rest of LATAM
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Productions, 2016 – 2027 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Process, 2016 – 2027 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2016 – 2027 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. GE Healthcare
11.2.1.1. Company Snapshot
11.2.1.2. Financial Performance
11.2.1.3. Product Benchmarking
11.2.1.4. Strategic Initiatives
11.3. Eppendorf AG
11.4. FiberCell Systems Inc.
11.5. Merck KGaA
11.6. INTEGRA Biosciences AG
11.7. Cellab GmbH
11.8. Pall Corp.
11.9. Sartorius AG
11.10. Thermo Fisher Scientific, Inc.
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Antibody production market: Productions Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Productions
TABLE Global antibody production market, by Productions 2016-2027 (USD Million)
TABLE Antibody production market: Process Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Process
TABLE Global antibody production market, by Process 2016-2027 (USD Million)
TABLE Antibody production market: End-Use Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by End-Use
TABLE Global antibody production market, by End-Use 2016-2027 (USD Million)
TABLE Antibody production market: Regional snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global antibody production market, by Region 2016-2027 (USD Million)
TABLE North America antibody production market, by Country, 2016-2027 (USD Million)
TABLE North America antibody production market, by Productions, 2016-2027 (USD Million)
TABLE North America antibody production market, by Process, 2016-2027 (USD Million)
TABLE North America antibody production market, by End-Use, 2016-2027 (USD Million)
TABLE Europe antibody production market, by Country, 2016-2027 (USD Million)
TABLE Europe antibody production market, by Productions, 2016-2027 (USD Million)
TABLE Europe antibody production market, by Process, 2016-2027 (USD Million)
TABLE Europe antibody production market, by End-Use, 2016-2027 (USD Million)
TABLE Asia Pacific antibody production market, by Country, 2016-2027 (USD Million)
TABLE Asia Pacific antibody production market, by Productions, 2016-2027 (USD Million)
TABLE Asia Pacific antibody production market, by Process, 2016-2027 (USD Million)
TABLE Asia Pacific antibody production market, by End-Use, 2016-2027 (USD Million)
TABLE Latin America antibody production market, by Country, 2016-2027 (USD Million)
TABLE Latin America antibody production market, by Production, 2016-2027 (USD Million)
TABLE Latin America antibody production market, by Process, 2016-2027 (USD Million)
TABLE Latin America antibody production market, by End-Use, 2016-2027 (USD Million)
TABLE Middle East and Africa antibody production market, by Country, 2016-2027 (USD Million)
TABLE Middle East and Africa antibody production market, by Production, 2016-2027 (USD Million)
TABLE Middle East and Africa antibody production market, by Process, 2016-2027 (USD Million)
TABLE Middle East and Africa antibody production market, by End-Use, 2016-2027 (USD Million)
List of Figures
FIGURE Antibody production market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2019
FIGURE Production segment market share analysis, 2020 & 2027
FIGURE Production segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Polyclonal antibody market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Murine market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Chimeric market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Humanized market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Process segment market share analysis, 2020 & 2027
FIGURE Process segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Large-scale bioreactors market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Single-use bioreactors market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Media market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Buffers and reagents market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Chromatography systems market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Chromatography resins market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Filtration systems market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Filtration consumables and accessories market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE End-Use segment market share analysis, 2020 & 2027
FIGURE End-Use segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Pharmaceutical and biotechnology companies market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGUREResearch laboratories market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGUREOthersmarket size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Regional segment market share analysis, 2020 & 2027
FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE North America antibody production market share and leading players, 2019
FIGURE Europe antibody production market share and leading players, 2019
FIGURE Asia Pacific antibody production market share and leading players, 2019
FIGURE Latin America antibody production market share and leading players, 2019
FIGURE Middle East and Africa antibody production market share and leading players, 2019
FIGURE North America market share analysis by country, 2019
FIGURE U.S. antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Canada antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Europe antibody production market share analysis by country, 2019
FIGURE Germany antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Spain antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Italy antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE UK antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE France antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of the Europe antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Asia Pacific antibody production market share analysis by country, 2019
FIGURE India antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE China antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Japan antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE South Korea antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Singapore antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of APAC antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America antibody production market share analysis by country, 2019
FIGURE Brazil antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Mexico antibody production market size, forecast, and trend analysis, 2016 to 2027 (USD Million)
FIGURE Argentina antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of LATAM antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa antibody production market share analysis by country, 2019
FIGURE Saudi Arabia antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE United Arab Emirates antibody production market size, forecast and trend analysis, 2016 to 2027 (USD Million)
